Clinical Trial Update: Azacitidine and Entinostat in Treating Patients With Newly Diagnosed Stage IA-IIIA Non-Small Lung Cancer Undergoing Surgery [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating azacitidine and entinostat in newly diagnosed stage IA-IIIA non-small cell lung cancer patients undergoing surgery; the trial was ter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Entinostat (entinostat)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Stage IA Non-Small Cell Lung Carcinoma, Stage IB Non-Small Cell Lung Carcinoma | Phase 1 | Status: TERMINATED